R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.

Key actions by disease

 

News

All →

Documents

All →

Disease Commodity Packages - Ebola virus disease

Overview

last update: 21 September 2018

WHO Team
Emergency Preparedness (WPE)
Editors
World Health Organization
Number of pages
4
Copyright
World Health Organization

Publications

All →
WHO target product profile for Bundibugyo virus disease vaccines, 14 July 2026

Bundibugyo virus disease, which is caused by Bundibugyo virus, is a severe filovirus infection with epidemic potential that requires the development of...

WHO Technical Advisory Group on Candidate Vaccine Prioritization: meeting report, 19 and 25 May 2026

This meeting report summarizes the deliberations and recommendations of the WHO Technical Advisory Group on Candidate Vaccine Prioritization (TAG-CVP)...

Related health topics